How hyperphosphorylated tau sabotages mitochondrial energy in the aging brain

Researchers have identified a feedback loop between hyperphosphorylated tau and mitochondrial dysfunction that accounts for significant neuronal death in tauopathies. When phosphorylated tau molecules enter mitochondria, they bind to NDUSF3, a critical component of the electron-transport chain, causing what scientists term "reverse electron transport"—electrons flow backward instead of forward, generating large quantities of reactive oxygen species that amplify neuroinflammation and protein damage. In fly and mouse models of tauopathy, as well as in human tauopathy-affected brain tissue, researchers confirmed this vicious-cycle mechanism where the resulting oxidative toxicity promotes further tau hyperphosphorylation, perpetuating neurodegeneration. The compound CPT prevents phosphorylated tau from binding to NDUSF3, halting reverse electron transport while preserving normal electron flow; in preclinical studies, it rescues behavioral deficits, reduces neuroinflammation, and mitigates neurodegeneration. For readers focused on brain longevity, this discovery opens a radically novel therapeutic avenue: rather than directly targeting tau aggregation, the strategy interrupts tau's toxic interaction with mitochondrial energy machinery—a fundamentally different approach to halting tauopathy progression.